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Asthma is one of the most common chronic diseases
worldwide, affecting an estimated 300 million people
around the globe [1]. The cause of one of every 250 deaths
annually, asthma is also associated with high costs both
economically and socially in terms of reduced quality of
life and of missed work days and school days for patients
and their families [1,2]. A large percentage of children and
adults with asthma also have allergic rhinitis. The reported
lifetime prevalence of allergic rhinitis among adults with
asthma ranges from 50% to 100%, varying by study
design and geographic locale [3]. While allergic rhinitis is
not a life-threatening disease, its toll on quality of life,
sleep, and daily functioning is well documented [4-7].
Asthma and allergic rhinitis are both inflammatory dis-
eases of the airways. The similarities between allergic rhin-
itis and asthma in epidemiologic and pathophysiologic
features suggest that allergic rhinitis and asthma represent
manifestations of the same syndrome, the chronic allergic
respiratory syndrome [8]. The Allergic Rhinitis Impact on
Asthma (ARIA) report in 2001 [5] summarized the evi-
dence supporting and describing the frequent clinical
association between asthma and allergic rhinitis and the
detrimental impact of allergic rhinitis on asthma. Citing
the concept of 'one airway, one disease,' the ARIA report
recommends that patients with persistent allergic rhinitis
be screened for asthma and those patients with asthma be
screened for allergic rhinitis, and that a combined strategy
be used to treat both upper and lower airways. Many of
the recommendations in ARIA relating to asthma manage-
ment, however, were not reflected in subsequent clinical
guidelines for asthma, including the Global Initiative for
Asthma guidelines [9,10]. Moreover, asthma and allergic
rhinitis often are not diagnosed in clinical practice [11].
Two international meetings were developed in response
to the need to highlight the role of inflammation in
asthma and the need for improved recognition of the rela-
tionship between asthma and allergic rhinitis. Both meet-
ings were held under the auspices of the University of
Southampton and the International Primary Care Respira-
tory Group, and were made possible through an educa-
tional grant by Merck & Co., Inc.
The first of these MetaForum conferences, held in London
in April 2004, was entitled 'Improving Asthma Therapy
through More Effective Control of Inflammation.' The sec-
ond meeting, 'MetaForum: Improving Outcomes for
Asthma Patients with Allergic Rhinitis,' took place in
December 2004 in London and, like the first, brought
together more than 40 leading experts in asthma and
allergic rhinitis from 20 countries. These meetings
included several presentations followed by an active dis-
cussion to reach consensus on the areas for action to
improve outcomes for patients with asthma and allergic
rhinitis. In the present supplement we include several of
the major papers presented at these conferences,
expanded and updated with more recent references.
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